CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel cell therapy for osteoarthritis using neonatal stem cells, which have superior anti-inflammatory properties compared to adult stem cells. The goal is to industrialize this solution for both veterinary and potential human applications, addressing a significant health issue in both an…
Society is experiencing a rise in chronic inflammatory diseases, mostly due to ageing, and sedentary lifestyle.
Osteoarthritis (OA) is one of the leading inflammatory diseases, affecting both humans (incidence 15%) and pets (20%), incurring disability and large economic burden.
Current pharmacological treatments for OA involve palliative therapies (NSAIDs) that work on the symptoms, becoming lengthy and expensive with multiple side effects.
In this context, regenerative medicine based on stem ce…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
